5-AMINOSALICYLIC ACID SUPPOSITORIES IN THE MANAGEMENT OF ULCERATIVE-COLITIS

被引：14
|
作者：
CAMPIERI, M
GIONCHETTI, P
BELLUZZI, A
BRIGNOLA, C
TORRESAN, F
TAMPIERI, M
IANNONE, P
MIGLIOLI, M
BARBARA, L
机构：
来源：
DISEASES OF THE COLON & RECTUM | 1989年 / 32卷 / 05期
关键词：
D O I：
10.1007/BF02563691
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：398 / 399
页数：2
相关论文
共 50 条
  • [21] TREATMENT OF ULCERATIVE-COLITIS WITH HIGH-DOSE 5-AMINOSALICYLIC ACID ENEMAS
    CAMPIERI, M
    BAZZOCCHI, G
    FRANZIN, G
    LANFRANCHI, GA
    BRIGNOLA, C
    SARTI, F
    BATTOCCHIA, A
    LABO, G
    MONTE, PRD
    LANCET, 1981, 2 (8241): : 270 - 271
  • [22] EFFICACY OF 5-AMINOSALICYLIC ACID ENEMAS VERSUS HYDROCORTISONE ENEMAS IN ULCERATIVE-COLITIS
    CAMPIERI, M
    GIONCHETTI, P
    BELLUZZI, A
    BRIGNOLA, C
    MIGALDI, M
    TABANELLI, GM
    BAZZOCCHI, G
    MIGLIOLI, M
    BARBARA, L
    DIGESTIVE DISEASES AND SCIENCES, 1987, 32 (12) : S67 - S70
  • [23] RETROGRADE SPREAD OF 5-AMINOSALICYLIC ACID ENEMAS IN PATIENTS WITH ACTIVE ULCERATIVE-COLITIS
    CAMPIERI, M
    LANFRANCHI, GA
    BRIGNOLA, C
    BAZZOCCHI, G
    GIONCHETTI, P
    MINGUZZI, MR
    CAPPELLO, IP
    CORBELLI, C
    BOSCHI, S
    DISEASES OF THE COLON & RECTUM, 1986, 29 (02) : 108 - 110
  • [24] COMPARISON OF BUDESONIDE AND 5-AMINOSALICYLIC ACID ENEMAS IN ACTIVE DISTAL ULCERATIVE-COLITIS
    LEMANN, M
    GALIAN, A
    RUTGEERTS, P
    VANHEUVERZWIJN, R
    CORTOT, A
    VITEAU, JM
    ELEWAUT, A
    BELAICHE, J
    FROGUEL, E
    MODIGLIANI, R
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1995, 9 (05) : 557 - 562
  • [25] Significance of 5-Aminosalicylic Acid Intolerance in the Clinical Management of Ulcerative Colitis
    Mikami, Yohei
    Tsunoda, Junya
    Suzuki, Shohei
    Mizushima, Ichiro
    Kiyohara, Hiroki
    Kanai, Takanori
    DIGESTION, 2023, 104 (01) : 58 - 65
  • [26] THE CORTICOSTEROID-SPARING EFFECT OF ORAL 5-AMINOSALICYLIC ACID FOR CHRONIC ULCERATIVE-COLITIS
    TREMAINE, WJ
    SCHROEDER, KW
    ILSTRUP, DM
    GASTROENTEROLOGY, 1987, 92 (05) : 1673 - 1673
  • [27] OPTIMUM DOSAGE OF 5-AMINOSALICYLIC ACID AS RECTAL ENEMAS IN PATIENTS WITH ACTIVE ULCERATIVE-COLITIS
    CAMPIERI, M
    GIONCHETTI, P
    BELLUZZI, A
    BRIGNOLA, C
    TAMPIERI, M
    IANNONE, P
    MIGLIOLI, M
    BARBARA, L
    GUT, 1991, 32 (08) : 929 - 931
  • [28] PREVENTION OF RELAPSE IN ULCERATIVE-COLITIS USING ORAL OR TOPICAL 5-AMINOSALICYLIC ACID THERAPY
    SUTHERLAND, LR
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 1993, 7 (02): : 232 - 236
  • [29] PROSTAGLANDIN CATABOLISM AND ULCERATIVE-COLITIS - EFFECT OF SULFASALAZINE, 5-AMINOSALICYLIC ACID AND OTHER DRUGS
    PACHECO, S
    HILLIER, K
    SMITH, CL
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1990, 23 (12) : 1323 - 1334
  • [30] ORAL 5-AMINOSALICYLIC ACID (ASACOL) FOR TREATMENT OF SYMPTOMATIC CHRONIC ULCERATIVE-COLITIS (CUC)
    SCHROEDER, KW
    TREMAINE, WJ
    GASTROENTEROLOGY, 1986, 90 (05) : 1620 - 1620
12345